PFIZER LTD. - 500680 - Closure of Trading Window
We would like to inform you that for the purpose of declaration of unaudited financial results of the Company, for the quarter ended June 30, 2023, the trading window of the Company shall remain closed from Friday, June 30, 2023 (Close of Business) till 48 hours after the results are made public. We request you to kindly take the above on record.
Pfizer to discontinue development of obesity drug due to side effects
Pfizer has been developing treatments to target weight loss in diabetes and obesity patients, as it races to target a market estimated to reach $100 billion by the end the of decade
'Govt kept same rules for Indian, foreign cos while getting Covid vaccines'
Foreign-made vaccines were not procured during the Covid pandemic as the firms were demanding indemnity, which was not made available to Indian vaccine manufacturers, Union Health Minister Mansukh Mandaviya has said, asserting that the "same rule applies for all". He also said that it was wrong to suggest that India stopped foreign made vaccines like that made by Moderna and Pfizer from coming to India. "We may have certain requirements and strengths and other countries may have some other strengths and needs. It is wrong to say that India stopped any country from coming to India.When they applied with required data, we gave them emergency use approvals just like we gave to Indian companies," Mandaviya said in an exclusive interview to PTI recently. However, their demands for indemnification and sovereign immunity waivers were a major impediment and eventually the government did not go ahead with it, the minister stated. "At that time, Sputnik vaccine was also there and so were Ind PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Limited has received an intimation for loss of share certificates and request for issuance of Letter of Confirmation from the Company's Shareholder. We shall issue the Letter of Confirmation upon completion of necessary formalities by the Shareholder. Please take the above on record.
BioNTech faces several lawsuits in Germany over Covid vaccine side effects
German drug company BioNTech is facing hundreds of lawsuits, worth one million euros, in country for alleged health damage due to its Covid-19 vaccine, co-developed with American pharma giant Pfizer PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Limited has received below mentioned request for issue of duplicate Share Certificate(s) from Shareholder(s). We shall issue the Letter of Confirmation(s) upon completion of necessary formalities by the shareholder(s). Please take the above on record.
Moderna, Pfizer hit with new patent lawsuits over COVID vaccines
The lawsuits add to a web of patent disputes between biotech companies over technology used in the coronavirus shots, including a case brought last year in Massachusetts by Moderna against Pfizer and its partner BioNTech. PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Limited has received requests for issue of duplicate Share Certificates from Shareholders. We shall issue the Letter of Confirmations upon completion of necessary formalities by the shareholders. Please take the above on record. PFIZER LTD. - 500680 - Pfizer Limited - Results Of The Postal Ballot (E-Voting).
Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, enclosed herewith please find the results of e-voting on the aforesaid resolution in the prescribed format along with Scrutinizer's Report issued by Mr. Nrupang Dholakia, Scrutinizer. Request you to kindly take the same on record. PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Limited has received requests for issue of duplicate Share Certificate(s) from Shareholders. We shall issue the Letter of Confirmation(s) upon completion of necessary formalities by the shareholder(s). Please take the above on record.